FDA Clears NOWDiagnostics’ ADEXUSDx® hCG Test for Professional Use

The ADEXUSDx hCG Test, NOWDiagnostics’ first FDA-cleared test available in the United States, is an immunoassay used for the qualitative detection of human chorionic gonadotropin (hCG) in human whole blood, plasma or serum. The test is an early detection aid for pregnancy for health care professionals in a variety of clinical and critical care settings. Depending on the woman and her pregnancy, the ADEXUSDx hCG test can detect pregnancy approximately two to eight days earlier than commonly available urine-based tests. The ADEXUSDx hCG test results are available 10 minutes after the test is used.

Early detection of pregnancy is important for caregivers in order to avoid certain medications and procedures that could harm a fetus. Unfortunately, clinics across the country are experiencing too many false-negative results…read more.

Check out what is making the news

Find out the latest in diagnostics testing.

First and Only In-Home Test for Syphilis Now Available to Consumers through Major Retailers and Public Health: NOWDiagnostics Launches First To Know® Syphilis Test Across the U.S.

Todd Simpson

With syphilis cases on the rise, NOWDx’s over-the-counter test offers rapid, in-home results in minutes and is now available nationwide in thousands of pharmacies, retail, and drugstore locations and on Amazon SPRINGDALE, Ark. – November 19, 2024 – NOWDiagn...

NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.

Todd Simpson

As syphilis cases surge nationwide, the collaboration will bring the First To Know® over-the-counter test to clinicians and patients across professional and hospital settingsSPRINGDALE, ARK. – October 16, 2024 – NOWDiagnostics, Inc. (NOWDx), a developer of ...

NOWDiagnostics First To Know® Syphilis Test Receives FDA De Novo Marketing Authorization for Over-the-Counter Use

Todd Simpson

First and only rapid syphilis test with in-home results in minutes, addressing growing epidemic SPRINGDALE, ARK. – August 16, 2024 – NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announce...